Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002381908 | SCV002689692 | uncertain significance | Inborn genetic diseases | 2017-05-31 | criteria provided, single submitter | clinical testing | The p.H4389R variant (also known as c.13166A>G), located in coding exon 73 of the DYNC1H1 gene, results from an A to G substitution at nucleotide position 13166. The histidine at codon 4389 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002538888 | SCV003469283 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-05-18 | criteria provided, single submitter | clinical testing | |
Genesis Genome Database | RCV000856992 | SCV000999560 | uncertain significance | Charcot-Marie-Tooth disease | 2019-08-14 | no assertion criteria provided | research |